Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177


APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.

Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L.

Am J Clin Nutr. 2012 Oct;96(4):917-22. Epub 2012 Aug 22.


Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.

Xu M, Ng SS, Bray GA, Ryan DH, Sacks FM, Ning G, Qi L.

J Nutr. 2015 Jun;145(6):1289-94. doi: 10.3945/jn.115.212514. Epub 2015 Apr 29.


Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity.

Zheng Y, Huang T, Zhang X, Rood J, Bray GA, Sacks FM, Qi L.

J Nutr. 2015 May;145(5):977-82. doi: 10.3945/jn.115.210005. Epub 2015 Mar 11.


APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.

Sánchez-Moreno C, Ordovás JM, Smith CE, Baraza JC, Lee YC, Garaulet M.

J Nutr. 2011 Mar;141(3):380-5. doi: 10.3945/jn.110.130344. Epub 2011 Jan 5.


Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.

Heianza Y, Ma W, Huang T, Wang T, Zheng Y, Smith SR, Bray GA, Sacks FM, Qi L.

Diabetes Care. 2016 Nov;39(11):1909-1914. Epub 2016 Aug 31.


Changes of plasma lipids during weight reduction in females depends on APOA5 variants.

Suchanek P, Lorenzova A, Poledne R, Hubacek JA.

Ann Nutr Metab. 2008;53(2):104-8. doi: 10.1159/000165358. Epub 2008 Oct 22.


APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study.

Corella D, Lai CQ, Demissie S, Cupples LA, Manning AK, Tucker KL, Ordovas JM.

J Mol Med (Berl). 2007 Feb;85(2):119-28. Epub 2007 Jan 9.


FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial.

Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L.

Diabetes. 2012 Nov;61(11):3005-11. doi: 10.2337/db11-1799. Epub 2012 Aug 13. Erratum in: Diabetes. 2013 Feb;62(2):662. Smith, Steven R [added]; Bray, George A [added].


IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.

Qi Q, Xu M, Wu H, Liang L, Champagne CM, Bray GA, Sacks FM, Qi L.

Diabetes Care. 2013 Nov;36(11):3442-7. doi: 10.2337/dc13-0018. Epub 2013 Sep 5.


Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.

Domínguez-Reyes T, Astudillo-López CC, Salgado-Goytia L, Muñoz-Valle JF, Salgado-Bernabé AB, Guzmán-Guzmán IP, Castro-Alarcón N, Moreno-Godínez ME, Parra-Rojas I.

Lipids Health Dis. 2015 Sep 13;14:106. doi: 10.1186/s12944-015-0112-4.


Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials.

Zheng Y, Ceglarek U, Huang T, Li L, Rood J, Ryan DH, Bray GA, Sacks FM, Schwarzfuchs D, Thiery J, Shai I, Qi L.

Am J Clin Nutr. 2016 Feb;103(2):505-11. doi: 10.3945/ajcn.115.117689. Epub 2016 Jan 20.


Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women.

Lim HH, Choi M, Kim JY, Lee JH, Kim OY.

Nutr Res. 2014 Oct;34(10):827-36. doi: 10.1016/j.nutres.2014.08.018. Epub 2014 Sep 6.


Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.

Mattei J, Demissie S, Tucker KL, Ordovas JM.

J Nutr. 2009 Dec;139(12):2301-8. doi: 10.3945/jn.109.109900. Epub 2009 Oct 14.


Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial.

Mirzaei K, Xu M, Qi Q, de Jonge L, Bray GA, Sacks F, Qi L.

Am J Clin Nutr. 2014 Feb;99(2):392-9. doi: 10.3945/ajcn.113.072066. Epub 2013 Dec 11.


Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL; SMART Study Group.

PLoS One. 2014 Jun 30;9(6):e101082. doi: 10.1371/journal.pone.0101082. eCollection 2014.


Effects of a vegetarian diet and treatment preference on biochemical and dietary variables in overweight and obese adults: a randomized clinical trial.

Burke LE, Hudson AG, Warziski MT, Styn MA, Music E, Elci OU, Sereika SM.

Am J Clin Nutr. 2007 Sep;86(3):588-96.


CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.

Qi Q, Durst R, Schwarzfuchs D, Leitersdorf E, Shpitzen S, Li Y, Wu H, Champagne CM, Hu FB, Stampfer MJ, Bray GA, Sacks FM, Shai I, Qi L.

J Lipid Res. 2015 Mar;56(3):713-21. doi: 10.1194/jlr.P055715. Epub 2014 Dec 29.


The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study.

Hubacek JA, Peasey A, Kubinova R, Pikhart H, Bobak M.

Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):243-7. doi: 10.1016/j.numecd.2013.08.008. Epub 2013 Oct 9.

Supplemental Content

Support Center